• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本多模式干预预防痴呆症试验(J-MINT):一项为期 18 个月、多中心、随机、对照试验的研究方案。

The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial.

机构信息

Takashi Sakurai, 7-430 Morioka, Obu, Aichi, 474-8511, Japan, Tel: +81-562-46-2311, E-mail:

出版信息

J Prev Alzheimers Dis. 2021;8(4):465-476. doi: 10.14283/jpad.2021.29.

DOI:10.14283/jpad.2021.29
PMID:34585222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8187136/
Abstract

BACKGROUND/OBJECTIVES: The Japan-multimodal intervention trial for prevention of dementia (J-MINT) is intended to verify the effectiveness of multi-domain interventions and to clarify the mechanism of cognitive improvement and deterioration by carrying out assessment of dementia-related biomarkers, omics analysis and brain imaging analysis among older adults at high risk of dementia. Moreover, the J-MINT trial collaborates with partnering private enterprises in the implementation of relevant interventional measures. This manuscript describes the study protocol.

DESIGN/SETTING: Eighteen-month, multi-centered, randomized controlled trial.

PARTICIPANTS

We plan to recruit 500 older adults aged 65-85 years with mild cognitive impairment. Subjects will be centrally randomized into intervention and control groups at a 1:1 allocation ratio using the dynamic allocation method with all subjects stratified by age, sex, and cognition.

INTERVENTION

The multi-domain intervention program includes: (1) management of vascular risk factors; (2) group-based physical exercise and self-monitoring of physical activity; (3) nutritional counseling; and (4) cognitive training. Health-related information will be provided to the control group every two months.

MEASUREMENTS

The primary and secondary outcomes will be assessed at baseline, 6-, 12-, and 18-month follow-up. The primary outcome is the change from baseline to 18 months in a global composite score combining several neuropsychological domains. Secondary outcomes include: cognitive change in each neuropsychological test, incident dementia, changes in blood and dementia-related biomarkers, changes in geriatric assessment including activities of daily living, frailty status and neuroimaging, and number of medications taken.

CONCLUSIONS

This trial that enlist the support of private enterprises will lead to the creation of new services for dementia prevention as well as to verify the effectiveness of multi-domain interventions for dementia prevention.

摘要

背景/目的:日本多模式干预预防痴呆症试验(J-MINT)旨在通过对痴呆相关生物标志物、组学分析和脑成像分析进行评估,验证多领域干预措施的有效性,并阐明认知改善和恶化的机制。此外,J-MINT 试验与合作的私营企业合作实施相关干预措施。本文描述了研究方案。

设计/设置:为期 18 个月的多中心、随机对照试验。

参与者

我们计划招募 500 名年龄在 65-85 岁之间、有轻度认知障碍的老年人。采用全部分层(按年龄、性别和认知分组)的动态分配方法,以 1:1 的比例将受试者中央随机分配到干预组和对照组。

干预

多领域干预方案包括:(1)管理血管危险因素;(2)以小组为基础的身体锻炼和身体活动自我监测;(3)营养咨询;(4)认知训练。对照组每两个月将收到一次健康相关信息。

测量

主要和次要结局将在基线、6、12 和 18 个月随访时进行评估。主要结局是从基线到 18 个月的全球综合评分变化,该评分综合了几个神经心理学领域。次要结局包括:每个神经心理学测试的认知变化、痴呆的发生、血液和痴呆相关生物标志物的变化、包括日常生活活动在内的老年评估的变化、虚弱状态和神经影像学变化,以及服用的药物数量。

结论

这项试验得到了私营企业的支持,将为预防痴呆症创造新的服务,并验证预防痴呆症的多领域干预措施的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb2/12280762/d133e8ac51d0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb2/12280762/a3a4e390f488/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb2/12280762/0e0c3fa04509/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb2/12280762/d133e8ac51d0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb2/12280762/a3a4e390f488/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb2/12280762/0e0c3fa04509/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb2/12280762/d133e8ac51d0/gr3.jpg

相似文献

1
The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial.日本多模式干预预防痴呆症试验(J-MINT):一项为期 18 个月、多中心、随机、对照试验的研究方案。
J Prev Alzheimers Dis. 2021;8(4):465-476. doi: 10.14283/jpad.2021.29.
2
The Japan-Multimodal Intervention Trial for Prevention of Dementia PRIME Tamba (J-MINT PRIME Tamba): Study protocol of a randomised controlled multi-domain intervention trial.日本多模式干预预防痴呆症 PRIME 项目(J-MINT PRIME Tamba):一项随机对照多领域干预试验的研究方案。
Arch Gerontol Geriatr. 2023 Jan;104:104803. doi: 10.1016/j.archger.2022.104803. Epub 2022 Aug 31.
3
The Multi-Domain Intervention Trial in Older Adults With Diabetes Mellitus for Prevention of Dementia in Japan: Study Protocol for a Multi-Center, Randomized, 18-Month Controlled Trial.日本老年糖尿病患者预防痴呆的多领域干预试验:一项多中心、随机、18个月对照试验的研究方案。
Front Aging Neurosci. 2021 Jul 12;13:680341. doi: 10.3389/fnagi.2021.680341. eCollection 2021.
4
An 18-month multimodal intervention trial for preventing dementia: J-MINT PRIME Tamba.一项为期 18 个月的预防痴呆多模式干预试验:J-MINT PRIME Tamba。
Alzheimers Dement. 2024 Oct;20(10):6972-6983. doi: 10.1002/alz.14170. Epub 2024 Sep 4.
5
Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.身体、大脑、生活对认知衰退的影响(BBL-CD):针对主观认知衰退和轻度认知障碍的多领域痴呆风险降低随机对照试验的方案。
Clin Interv Aging. 2018 Nov 21;13:2397-2406. doi: 10.2147/CIA.S182046. eCollection 2018.
6
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER): Study Design and Protocol.新加坡老年干预研究以减少认知能力下降和身体虚弱(SINGER):研究设计和方案。
J Prev Alzheimers Dis. 2022;9(1):40-48. doi: 10.14283/jpad.2022.5.
7
The Multi-domain Lifestyle Intervention for Cognitive Impairment in Community-Dwelling Older Adults in Hangzhou (The Heritage Study): Study Design and Protocol.《杭州市社区居住老年人认知障碍的多领域生活方式干预(遗产研究):研究设计与方案》。
J Prev Alzheimers Dis. 2024;11(3):601-611. doi: 10.14283/jpad.2024.59.
8
Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).血液生物标志物作为有氧运动和认知训练(ACT)治疗反应的替代终点在遗忘型轻度认知障碍中的应用:一项随机对照试验(ACT 试验)的血液生物标志物研究方案。
Trials. 2020 Jan 6;21(1):19. doi: 10.1186/s13063-019-3798-1.
9
AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients.AgeWell.de - 一项针对老年初级保健患者认知能力下降的实用多中心集群随机对照预防试验的研究方案。
BMC Geriatr. 2019 Aug 1;19(1):203. doi: 10.1186/s12877-019-1212-1.
10
Delaying cognitive and physical decline through multidomain interventions for residents with mild-to-moderate dementia in dementia care units in Taiwan: A prospective cohort study.台湾失智症照护机构中针对轻至中度失智症患者的多领域干预对延缓认知和身体衰退的影响:一项前瞻性队列研究
Geriatr Gerontol Int. 2017 Apr;17 Suppl 1:36-43. doi: 10.1111/ggi.13035.

引用本文的文献

1
CITA GO-ON study. A community based multidomain lifestyle intervention to prevent cognitive decline. Protocol design and recruitment process.CITA GO-ON研究。一项基于社区的多领域生活方式干预预防认知衰退的研究。方案设计与招募过程。
Front Aging Neurosci. 2025 Jun 16;17:1539711. doi: 10.3389/fnagi.2025.1539711. eCollection 2025.
2
Multidomain interventions for preventing cognitive decline in older adults with type 2 diabetes and mild cognitive impairment: Secondary analysis of the J-MINT: Multidomain intervention in type 2 diabetes.多领域干预措施预防2型糖尿病合并轻度认知障碍老年人认知功能减退:J-MINT(2型糖尿病多领域干预)的二次分析
JAR Life. 2025 Jun 9;14:100016. doi: 10.1016/j.jarlif.2025.100016. eCollection 2025.
3

本文引用的文献

1
Oral Frailty Index-8 in the risk assessment of new-onset oral frailty and functional disability among community-dwelling older adults.口腔虚弱指数-8 用于评估社区居住的老年人新发口腔虚弱和功能障碍的风险。
Arch Gerontol Geriatr. 2021 May-Jun;94:104340. doi: 10.1016/j.archger.2021.104340. Epub 2021 Jan 19.
2
World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia.世界范围内 FINGERS 网络:降低痴呆风险和预防痴呆的全球方法。
Alzheimers Dement. 2020 Jul;16(7):1078-1094. doi: 10.1002/alz.12123. Epub 2020 Jul 5.
3
Tracing temporal trends in dementia incidence over 25 years in central Stockholm, Sweden.
Multidomain interventions for prevention of dementia: Achievements, challenges and future perspectives.
预防痴呆的多领域干预措施:成就、挑战与未来展望。
Geriatr Gerontol Int. 2025 Aug;25(8):1015-1034. doi: 10.1111/ggi.70088. Epub 2025 Jun 17.
4
Genetic background and multidomain interventions in mild cognitive impairment.轻度认知障碍的遗传背景与多领域干预措施
Alzheimers Res Ther. 2025 Jun 10;17(1):130. doi: 10.1186/s13195-025-01764-0.
5
Adherence and intensity in multimodal lifestyle-based interventions for cognitive decline prevention: state-of-the-art and future directions.基于多模式生活方式的认知衰退预防干预措施的依从性和强度:现状与未来方向。
Alzheimers Res Ther. 2025 Mar 17;17(1):61. doi: 10.1186/s13195-025-01691-0.
6
Factors associated with adherence to tablet-based cognitive training: J-MINT study.与基于平板电脑的认知训练依从性相关的因素:J-MINT研究。
Alzheimers Dement (N Y). 2025 Mar 10;11(1):e70062. doi: 10.1002/trc2.70062. eCollection 2025 Jan-Mar.
7
Adherence and aerobic exercise intensity in live online exercise sessions for older adults with mild cognitive impairment: Insights from the Japan-Multimodal Intervention Trial for the Prevention of Dementia.轻度认知障碍老年人在线直播运动课程中的依从性和有氧运动强度:来自日本预防痴呆多模式干预试验的见解。
JAR Life. 2025 Feb 7;14:100003. doi: 10.1016/j.jarlif.2025.100003. eCollection 2025.
8
Reduction in the incidence of cognitive impairment and related costs through an innovative health awareness programme in rural Japan.通过在日本农村开展创新的健康意识项目,降低认知障碍的发病率和相关成本。
PLoS One. 2024 Oct 14;19(10):e0311826. doi: 10.1371/journal.pone.0311826. eCollection 2024.
9
An 18-month multimodal intervention trial for preventing dementia: J-MINT PRIME Tamba.一项为期 18 个月的预防痴呆多模式干预试验:J-MINT PRIME Tamba。
Alzheimers Dement. 2024 Oct;20(10):6972-6983. doi: 10.1002/alz.14170. Epub 2024 Sep 4.
10
Improving Neurological Health in Aging Via Neuroplasticity-Based Computerized Exercise: Protocol for a Randomized Controlled Trial.通过基于神经可塑性的计算机化运动改善老年人的神经健康:一项随机对照试验方案
JMIR Res Protoc. 2024 Aug 8;13:e59705. doi: 10.2196/59705.
追踪 25 年来瑞典斯德哥尔摩中心区痴呆症发病率的时间趋势。
Alzheimers Dement. 2020 May;16(5):770-778. doi: 10.1002/alz.12073. Epub 2020 Apr 9.
4
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.亚洲肌少症工作组:2019年肌少症诊断与治疗共识更新
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.
5
Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS.多领域干预以预防认知障碍、阿尔茨海默病和痴呆:从 FINGER 到全球 FINGERS。
J Prev Alzheimers Dis. 2020;7(1):29-36. doi: 10.14283/jpad.2019.41.
6
CogEvo, a cognitive function balancer, is a sensitive and easy psychiatric test battery for age-related cognitive decline.CogEvo,一种认知功能平衡器,是一种敏感且易于使用的精神科测试组合,用于与年龄相关的认知能力下降。
Geriatr Gerontol Int. 2020 Mar;20(3):248-255. doi: 10.1111/ggi.13847. Epub 2019 Dec 18.
7
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).日本高血压学会高血压管理指南(JSH 2019)。
Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9.
8
Alzheimer's disease drug development pipeline: 2019.2019年阿尔茨海默病药物研发进程
Alzheimers Dement (N Y). 2019 Jul 9;5:272-293. doi: 10.1016/j.trci.2019.05.008. eCollection 2019.
9
Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials.预防痴呆的多领域干预措施的依从性:来自 FINGER 和 MAPT 试验的数据。
Alzheimers Dement. 2019 Jun;15(6):729-741. doi: 10.1016/j.jalz.2019.03.005. Epub 2019 Apr 30.
10
Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients.血浆神经丝轻链:唐氏综合征成年患者痴呆的潜在预后生物标志物。
PLoS One. 2019 Apr 5;14(4):e0211575. doi: 10.1371/journal.pone.0211575. eCollection 2019.